“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.
A seed sold in bodybuilding for testosterone. This is precisely its least well-documented use: its best studies concern blood glucose and cholesterol.
Medical advice is essential in cases of treated diabetes: fenugreek lowers blood glucose and its effect adds to that of the treatment. The most comprehensive meta-analysis on diabetes reveals neither hepatic nor renal toxicity. Also worth knowing: the evidence is not of the same quality depending on the use, and this is the entire point of this profile. On blood glucose and lipids, it relies on dozens of randomized trials — but the authors themselves point out uneven quality and strong heterogeneity from one study to another. On testosterone, the one sought after in the gym, the meta-analysis brings together only four trials, and the one focusing on athletes explicitly speaks of a small effect. Several of the most favorable trials involve patented extracts, and two of them are open-label, without placebo: this is the lowest level of evidence for a product sold on this precise promise. Weight and BMI, meanwhile, do not budge — a meta-analysis of twelve trials says so in black and white. Finally, on milk supply, the effect exists but remains clearly inferior to that of other herbs compared in the same analysis, and on painful periods the quality of the evidence is considered low.
Two worlds of dosages depending on the use. For blood glucose, whole seeds or powder are used at high doses: the effect on blood pressure only appears above 15 g per day. For testosterone and libido, standardised extracts are used at 400 to 600 mg per day — two different products under the same name.
Beyond its role on male testosterone, fenugreek is also effective for reducing hot flashes and improving hormonal balance in perimenopausal women.
This systematic review and meta-analysis explored the effect of fenugreek on the severity of dysmenorrhea in women, including four articles. The results indicated that the intensity of pain caused by primary dysmenorrhea decreased with fenugreek compared to placebo. The study highlights that the quality of evidence is low, suggesting that the true effect is uncertain and that trials with a more robust methodology are needed.
Hassanzadeh R, Shabani F, Montazeri M, Mirghafourvand M. — Current drug research reviews (2024) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more